Please note: This trial has finished recruiting and is not accepting new participants.

Research Center: Texas Center for Drug Development
Location: 6550 Mapleridge St., Suite 201, Houston, TX
Lead Doctor: Dr. Teresa Becker
Ethics Committee: This material has been reviewed and approved by the Schulman Institutional Review Board

Background

Chlamydia is the most commonly reported STD in the United States. Currently, the best way to prevent chlamydia is by practicing abstinence or maintaining a monogamous relationship with a non-infected partner. Researchers are exploring if there is an option for STD prevention that can be controlled by women.

In order to participate in a research study, you must be a woman between who has been diagnosed with chlamydia or gonorrhea within the past 4 months. Participants are required to attend study site visits over a few months and will be compensated up to $1,400 upon completion of a study.

Benefits of Participation

• You will receive up to $1,400 upon completion of a study.
• You will receive closely monitored medical care for the duration of your participation.
• You will be helping to improve preventative care for women against chlamydia and gonorrhea
• You will be helping to advance medical research.
  

Your Rights

• If you decide to participate in a study and later feel that you no longer wish to be part of it, you may withdraw at any time.
• Your records relating to your participation in any study and any other information received will be kept strictly confidential, except as required by the law.
• Qualified health professionals will monitor your health as it relates to your participation

Who Can Participate?

• Women aged of 18 to 45 years old.
• You must be diagnosed with chlamydia or gonorrhea within the past 4 months and have a medical record showing diagnosis in order to participate in a clinical trial.
• Willing to use a reliable form of contraception for the duration of your participation such as oral contraceptives, birth control implants, IUDs, or tubal ligation.
• Able to attend visits at the study sites in Houston, TX within a period of a few months.